An interventional study of Robotic surgery in Absolute Uterine Factor Infertility, sponsored by Sahlgrenska University Hospital. Terminated at 2 sites in Sweden. Open to female participants aged 18 Years to 38 Years. Per ClinicalTrials.gov, last updated 2024-06-24.
Sponsored by Sahlgrenska University Hospital · Not applicable, Interventional, and Treatment
Robotic assisted organ procurement and robotic assisted transplantation in live donor uterus transplantation
Inclusion; absolute uterine factor infertility, age between 18 and 38, BMI less than 28, non-smoker
2,506 studies on the registry are indexed under Infertility; 407 are open to participants now.
This study's enrollment of 2 is below the median of 120 across 1,698 interventional studies indexed under Infertility.
Browse Infertility studies →Sahlgrenska University Hospital is the lead sponsor of 259 studies on the registry; 68 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Uterine factor infertility, age 18-38 years, psychological stable, in steady relationship.
Exclusion Criteria:
Smoking, systemic disease, psychological instability
Robotic surgery in both live donor and recipient
Procedure: Robotic surgery
Robotoc surgery (Da Vinci) in both donor and recipient
Surgical success
Uterus with viability and regular menstruations
Time frame: 0-4 months
Pregnancy rate
Pregnancy rate per ET
Time frame: 10-48 months
Live birth rate per attempted and surgically succesful transplantation
Live birth rates
Time frame: 19-72 months
Plan to share: No — Only group dat will be published and shared after publication, in order to avoid identification of a person
No publications or documents are linked to this record.
This study is terminated, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sahlgrenska University Hospital